Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Shivani Gupta, César A Briceño & Raymond S Douglas. (2013) Customized minimally invasive orbital decompression for thyroid eye disease. Expert Review of Ophthalmology 8:3, pages 255-266.
Read now
Read now
Sang-Rog Oh, Ayelet Priel, David B Granet, Leah Levi, Bobby S Korn & Don O Kikkawa. (2011) Thyroid-related orbitopathy: a multidisciplinary perspective. Expert Review of Ophthalmology 6:1, pages 43-53.
Read now
Read now
Luigi Bartalena, Adriana Lai & Maria Laura Tanda. (2008) Perspectives in pharmacological management of Graves’ hyperthyroidism and orbitopathy. Expert Review of Clinical Immunology 4:3, pages 321-329.
Read now
Read now
Articles from other publishers (37)
Rosa M. M. Gynthersen, Christen Rune Stensvold, Signe Ledou Nielsen, Holger Jon Møller, Henrik Vedel Nielsen, Anne‐Mette Lebech, Jeppe Romme Christensen, Helene Mens & Daniel El Fassi. (2023)
Neoehrlichia mikurensis
—An emerging opportunistic tick‐borne infection in immunosuppressed patients
. Journal of Internal Medicine 293:6, pages 782-790.
Crossref
Crossref
E. J. Neag & T. J. Smith. (2021) 2021 update on thyroid-associated ophthalmopathy. Journal of Endocrinological Investigation 45:2, pages 235-259.
Crossref
Crossref
Claudio Marcocci & Terry J. Smith. 2018. Thyroid Diseases. Thyroid Diseases
451
488
.
Sofie Bliddal, Claus Henrik Nielsen & Ulla Feldt-Rasmussen. (2017) Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Research 6, pages 1776.
Crossref
Crossref
Geoffrey E. Rose & David H. Verity. 2017. Emergencies of the Orbit and Adnexa. Emergencies of the Orbit and Adnexa
171
178
.
Akira Kurozumi, Yosuke Okada, Tadashi Arao, Yusuke Miyazaki, Maiko Yoshikawa, Keiichi Torimoto, Satoshi Kubo, Shingo Nakayamada & Yoshiya Tanaka. (2016) Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report. Endocrinology, Diabetes & Metabolism Case Reports.
Crossref
Crossref
Claudio Marcocci & Terry J. Smith. 2017. Thyroid Diseases. Thyroid Diseases
1
39
.
Syed Khalid Imam. 2016. Thyroid Disorders. Thyroid Disorders
147
168
.
Birte Kristensen, Laszlo Hegedüs, Steven K. Lundy, Marie K. Brimnes, Terry J. Smith & Claus H. Nielsen. (2015) Characterization of Regulatory B Cells in Graves’ Disease and Hashimoto’s Thyroiditis. PLOS ONE 10:5, pages e0127949.
Crossref
Crossref
Akira Kurozumi, Yosuke Okada, Tadashi Arao, Manabu Narisawa, Keiichi Torimoto, Sunao Yamamoto & Yoshiya Tanaka. (2015) Induction of thyroid remission using rituximab in a patient with type 3 autoimmune polyglandular syndrome including Graves’ disease and type 1 diabetes mellitus: A case report. Endocrine Journal 62:1, pages 69-75.
Crossref
Crossref
Marie Klinge Brimnes, Bjarke Endel Hansen, Leif Kofoed Nielsen, Morten Hanefeld Dziegiel & Claus Henrik Nielsen. (2014) Uptake and Presentation of Myelin Basic Protein by Normal Human B Cells. PLoS ONE 9:11, pages e113388.
Crossref
Crossref
Tony Shang-Chuan Chen, Edwin Figueira, Oliver C. F. Lau, Penny A. McKelvie, Robert I. Smee, Laughlin C. Dawes, Ashish Agar, Geoff Wilcsek & Ian C. Francis. (2014) Successful “Medical” Orbital Decompression With Adjunctive Rituximab for Severe Visual Loss in IgG4-Related Orbital Inflammatory Disease With Orbital Myositis. Ophthalmic Plastic & Reconstructive Surgery 30:5, pages e122-e125.
Crossref
Crossref
Sunny Shen, Anita Chan, Petros P. Sfikakis, Andrea Low Hsiu Ling, Efstathios T. Detorakis, Kostas G. Boboridis & Ioannis Mavrikakis. (2013) B-Cell Targeted Therapy With Rituximab for Thyroid Eye Disease: Closer to the Clinic. Survey of Ophthalmology 58:3, pages 252-265.
Crossref
Crossref
D H Verity & G E Rose. (2013) Acute thyroid eye disease (TED): Principles of medical and surgical management. Eye 27:3, pages 308-319.
Crossref
Crossref
Bingbing Zha, Luman Wang, Xiaoming Liu, Jun Liu, Zaoping Chen, Jiong Xu, Li Sheng, Yiming Li & Yiwei Chu. (2012) Decrease in Proportion of CD19+CD24hiCD27+ B Cells and Impairment of Their Suppressive Function in Graves’ Disease. PLoS ONE 7:11, pages e49835.
Crossref
Crossref
Noriyasu Hashida, Nobuyuki Ohguro & Kohji Nishida. (2012) Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma. Translational Vision Science & Technology 1:3, pages 1.
Crossref
Crossref
Anina Langkjær, Birte Kristensen, Bjarke E. Hansen, Heidi Schultz, Laszlo Hegedüs & Claus H. Nielsen. (2012) B-cell exposure to self-antigen induces IL-10 producing B cells as well as IL-6- and TNF-α-producing B-cell subsets in healthy humans. Clinical Immunology 145:1, pages 1-10.
Crossref
Crossref
Michael Gonzales, Carmel Fratianni, Chaitanya Mamillapali & Romesh Khardori. (2012) Immunotherapy in Miscellaneous Medical Disorders Graves Ophthalmopathy, Asthma, and Regional Painful Syndrome. Medical Clinics of North America 96:3, pages 635-654.
Crossref
Crossref
Byung-Chun ParkKyung-In WooYoon-Duck Kim. (2012) Three Cases of Rituximab Treatment for Orbital Inflammatory Disease. Journal of the Korean Ophthalmological Society 53:5, pages 721.
Crossref
Crossref
Claus H. Nielsen & Klaus Bendtzen. 2012. Naturally Occurring Antibodies (NAbs). Naturally Occurring Antibodies (NAbs)
116
132
.
Anders E. Pedersen, Mette B Jungersen & Charlotte D. Pedersen. (2011) Monocytes mediate shaving of B-cell-bound anti-CD20 antibodies. Immunology 133:2, pages 239-245.
Crossref
Crossref
Luigi Bartalena. (2011) The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy. The Journal of Clinical Endocrinology & Metabolism 96:3, pages 592-599.
Crossref
Crossref
Laszlo Hegedüs, Terry J. Smith, Raymond S. Douglas & Claus H. Nielsen. (2010) Targeted biological therapies for Graves’ disease and thyroid‐associated ophthalmopathy. Focus on B‐cell depletion with Rituximab. Clinical Endocrinology 74:1, pages 1-8.
Crossref
Crossref
Vibhavari M. Naik, Milind N. Naik, Robert A. Goldberg, Terry J. Smith & Raymond S. Douglas. (2010) Immunopathogenesis of Thyroid Eye Disease: Emerging Paradigms. Survey of Ophthalmology 55:3, pages 215-226.
Crossref
Crossref
Dinesh Khanna, Kelvin K.L. Chong, Nikoo F. Afifiyan, Catherine J. Hwang, Diana K. Lee, Helene Chokron Garneau, Robert A. Goldberg, Christine H. Darwin, Terry J. Smith & Raymond S. Douglas. (2010) Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated Ophthalmopathy. Ophthalmology 117:1, pages 133-139.e2.
Crossref
Crossref
Laszlo Hegedüs. (2009) Treatment of Graves' Hyperthyroidism: Evidence-Based and Emerging Modalities. Endocrinology and Metabolism Clinics of North America 38:2, pages 355-371.
Crossref
Crossref
Petros Perros & Gerasimos E. Krassas. (2009) Graves orbitopathy: a perspective. Nature Reviews Endocrinology 5:6, pages 312-318.
Crossref
Crossref
Daniel El Fassi, J. Paul Banga, Jacqueline A. Gilbert, Carolyn Padoa, Laszlo Hegedüs & Claus H. Nielsen. (2009) Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. Clinical Immunology 130:3, pages 252-258.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Ophthalmology 19:6, pages 541-548.
Crossref
Crossref
Raymond S. Douglas, Vibharavi Naik, Catherine J. Hwang, Nikoo F. Afifiyan, Andrew G. Gianoukakis, Daniel Sand, Shweta Kamat & Terry J. Smith. (2008) B Cells from Patients with Graves’ Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis. The Journal of Immunology 181:8, pages 5768-5774.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:5, pages 470-479.
Crossref
Crossref
Luigi Bartalena, Adriana Lai, Emanuele Compri, Claudio Marcocci & Maria Laura Tanda. (2008) Novel Immunomodulating Agents for Graves Orbitopathy. Ophthalmic Plastic & Reconstructive Surgery 24:4, pages 251-256.
Crossref
Crossref
Basil RapoportSandra M. McLachlan. (2008) Whither TSH Receptor Blocking Antibodies in the Treatment of Graves' Disease?. Thyroid 18:7, pages 695-696.
Crossref
Crossref
Shiguang Yu, Robert Dunn, Marilyn R. Kehry & Helen Braley-Mullen. (2008) B Cell Depletion Inhibits Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice. The Journal of Immunology 180:11, pages 7706-7713.
Crossref
Crossref
George S. Eisenbarth & Joy Jeffrey. (2008) The natural history of type 1A diabetes. Arquivos Brasileiros de Endocrinologia & Metabologia 52:2, pages 146-155.
Crossref
Crossref
Clara-Dina Cokonis, Carrie W. Cobb, Warren R. Heymann & Chad M. Hivnor. 2008. Thyroid Disorders with Cutaneous Manifestations. Thyroid Disorders with Cutaneous Manifestations
73
87
.
Daniel El Fassi, Ole Clemmensen, Claus H. Nielsen, Rona Z. Silkiss & Laszlo Hegedüs. (2007) Evidence of Intrathyroidal B-Lymphocyte Depletion after rituximab Therapy in a Patient with Graves’ Disease. The Journal of Clinical Endocrinology & Metabolism 92:10, pages 3762-3763.
Crossref
Crossref